trending Market Intelligence /marketintelligence/en/news-insights/trending/dFzL58y6TNRlf20UJiSkEw2 content esgSubNav
In This List

Bone Therapeutics appoints directors

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Bone Therapeutics appoints directors

Bone Therapeutics SA appointed Steve Swinson and Damian Marron to its board.

The nonexecutive directors will succeed Jacques Reymann and Jean-Jacques Verdickt who are retiring.

Swinson led Medtronic International Ltd.'s spine and biologics division for Canada and Western Europe before joining Bone Therapeutics.

Marron is the former CEO of Agalimmune Ltd.